Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
JCSE01 - Joint IASLC-CSCO-CAALC Session
- 07:00 - 11:15
- 9/07/2019
- Location: Toronto (1985)
- IASLC CME Accredited
- Type: Joint IASLC-CSCO-CAALC Session
- Track:
- Moderators:Chunxue Bai, Tony Mok, Yi-Long Wu, Qing Zhou, Nan Wu
-
+
JCSE01.11 - Efficacy and Safety of Sintilimab with Anlotinib as First-Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC)
10:05 - 10:15 | Presenter: Baohui Han | Author(s): Tianqing Chu, Runbo Zhong, Hua Zhong, Bo Zhang, Wei Zhang, Chunlei Shi, jialin Qian, Yuchen Han
- Abstract
Loading...
-
+
MA01 - Oligometastatic Disease
- 10:30 - 12:00
- 9/08/2019
- Location: Copenhagen (1980)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Oligometastatic NSCLC
- Moderators:Anne Marie Clasina Dingemans, Matthias Guckenberger
-
+
MA01.10 - Additional Local Consolidative Therapy Showed Survival Benefit Than EGFR-TKIs Alone in Bone Oligometastatic Lung Adenocarcinoma Patients
11:35 - 11:40 | Presenter: Fang Hu | Author(s): Changhui Li, Jianlin Xu, Jindong Guo, Yinchen Shen, Wei Nie, Xiaoxuan Zheng, Lixin Wang, Hai Zhang, Baohui Han, Xueyan Zhang
- Abstract
Loading...
-
+
OA03 - Systemic Therapies for SCLC: Novel Targets and Patients' Selection
- 13:30 - 15:00
- 9/08/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Oral Session
- Track: Small Cell Lung Cancer/NET
- Moderators:Christine Lee Hann, Makoto Nishio
-
+
OA03.02 - Effect of Anlotinib in Advanced Small Cell Lung Cancer Patients Previously Received Chemoradiotherapy: A Subgroup Analysis in ALTER 1202 Trial
13:40 - 13:50 | Presenter: Qiming Wang | Author(s): Ying Cheng, Kai Li, Jianhua Shi, Baohui Han, Lin Wu, Gongyan Chen, Jianxing He, Jie Wang, Haifeng Qin, Xiao-Ling Li
- Abstract
Loading...
-
+
EP1.01 - Advanced NSCLC
- 08:00 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
EP1.01-65 - The Relationship Between Preliminary Efficacy and Prognosis After First-Line EGFR-TKI Treatment of Advanced NSCLC
08:00 - 08:00 | Presenter: Yanwei Zhang | Author(s): Dongfang Chen, Tianqing Chu, Qing Chang, Liwen Xiong, Rong Qiao, Jiajun Teng, Baohui Han, Runbo Zhong
- Abstract
Loading...
-
+
EP1.03 - Biology
- 08:00 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Biology
-
+
EP1.03-11 - Mechanisms of Gefitinib Plus Pemetrexed on Human Non-Small Cell Lung Cancer
08:00 - 08:00 | Presenter: Yuqing Lou | Author(s): Jianlin Xu, Yanwei Zhang, Jun Lu, Xueyan Zhang, Huimin Wang, Wei Zhang, Baohui Han
- Abstract
Loading... -
+
EP1.03-12 - IL-10 Promotes Tumor Aggressiveness in Non-Small Cell Lung Cancer via Down-Regulated the Expression Level of miR-125b
08:00 - 08:00 | Presenter: Yanwei Zhang | Author(s): Baohui Han
- Abstract
Loading... -
+
EP1.03-22 - Prognostic Value of Serum Inflammation Biomarkers in Early Stage Lung Adenocarcinoma
08:00 - 08:00 | Presenter: Yanwei Zhang | Author(s): Minjuan Hu, Baohui Han
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-03 - Efficacy and Safety of Biosimilar QL1101 Compared with Avastin in Patients with Non-Squamous Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Baohui Han | Author(s): Kai Li, Tianqing Chu, Minghong Bi, Helong Zhang, Yan Yu, Jianhua Shi, Xiaochun Zhang, Zhendong Chen, Cuicui Han, Tao Bai
- Abstract
Loading... -
+
P1.01-95 - Efficacy and Safety of Anlotinib in Combination with Chemotherapy as First-Line Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
09:45 - 09:45 | Presenter: Tianqing Chu | Author(s): Baohui Han, Xueyan Zhang, Hua Zhong, Bo Zhang, Huimin Wang, Aiqin Gu, Wei Zhang, Chunlei Shi, Runbo Zhong
- Abstract
Loading...
-
+
P1.04 - Immuno-oncology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P1.04-02 - Efficacy and Safety of Sintilimab with Anlotinib as First-Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC)
09:45 - 09:45 | Presenter: Baohui Han | Author(s): Tianqing Chu, Runbo Zhong, Hua Zhong, Bo Zhang, Wei Zhang, Chunlei Shi, jialin Qian, Yuchen Han
- Abstract
Loading...
-
+
MA13 - Going Back to the Roots!
- 14:00 - 15:30
- 9/09/2019
- Location: Vancouver (2003)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Moderators:Maurice Perol, Kaoru Kubota
-
+
MA13.11 - A Randomized Phase III Study of Cisplatin-Polymeric Micelle Paclitaxel vs Cisplatin-Solvent-Based Paclitaxel in 1st Line Advanced NSCLC
15:10 - 15:15 | Presenter: Yi-Long Wu | Author(s): Baohui Han, Meiqi Shi, Haiyan Tu, Aiqin Gu, Cheng Huang, Huijuan Wang, Zhuang Yu, Xiuwen Wang, Lejie Cao, Yongqian Shu, Huaqing Wang, Runxiang Yang, Xingya Li, Jianhua Chang, Yanping Hu, Peng Shen, Yi Hu, Zhongliang Guo, Min Tao, Yiping Zhang, Xunyan Liu, Qian Sun, Xin Zhang, Zuguang Jiang, Junhui Zhao, Feng Chen, Jing Sun, Duan Li, Jinsong Zhou
- Abstract
Loading...
-
+
OA11 - Decomplexifying Molecular Targets, Immunotherapy and Treatment Settings in the Real World
- 14:00 - 15:30
- 9/09/2019
- Location: Interlaken (1988)
- IASLC CME Accredited
- Type: Oral Session
- Track: Treatment in the Real World - Support, Survivorship, Systems Research
- Moderators:Kumar Prabhash, Jyoti D Patel
-
+
OA11.07 - Chemotherapy Plus EGFR-TKI as First-Line Treatment Provides Better Survival for EGFR Mutation NSCLC Patients: Update Data for NCT02148380
15:05 - 15:15 | Presenter: Wei Zhang | Author(s): Jianlin Xu, Yuqing Lou, Yanwei Zhang, Baohui Han
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P2.01-21 - Efficacy and Safety of Combing Anlotinib and Erlotinib as a First-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
10:15 - 10:15 | Presenter: Tianqing Chu | Author(s): Baohui Han, Chunlei Shi, Hua Zhong, Wei Zhang, Bo Zhang, Runbo Zhong, Xueyan Zhang
- Abstract
Loading... -
+
P2.01-23 - DUBLIN-3, a Phase (Ph) III Trial Comparing the Plinabulin (P)/Docetaxel(D) Combination with D Alone in Stage IIIb/IV NSCLC
10:15 - 10:15 | Presenter: Ramon W Mohanlal | Author(s): Yan Sun, Goetz H. Kloecker, Trevor Feinstein, Yuankai Shi, Baohui Han, Lyudmila Bazhenova, Lihua Du, Lan Huang
- Abstract
Loading... -
+
P2.01-31 - Preliminary Results of Second Generation ALK Inhibitor PLB1003: A Phase La Study
10:15 - 10:15 | Presenter: Baohui Han | Author(s): Tianqing Chu, jialin Qian, Bo Yan, Yanwei Zhang, Qing Chang
- Abstract
Loading... -
+
P2.01-85 - Schwann Cells Are Overexpressed and Inversely Correlated with Survival of Non-Small Cell Lung Cancer Patients
10:15 - 10:15 | Presenter: Yan Zhou | Author(s): Hua Zhong, Baohui Han
- Abstract
Loading...
